RNAi and CRISPR/Cas9 based in vivo models for drug discovery

被引：0
|
作者：
Premsrirut, Prem K.
Martin, Gregory
Dow, Lukas
Kim, Sang Yong
Zuber, Johannes
Lowe, Scott
Hannon, Greg
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-4188
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4188
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A CRISPR/Cas9 system to turn genes on in vivo
    不详
    LAB ANIMAL, 2018, 47 (02) : 24 - 24
  • [22] Combining Zebrafish and CRISPR/Cas9: Toward a More Efficient Drug Discovery Pipeline
    Cornet, Carles
    Di Donato, Vincenzo
    Terriente, Javier
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [23] Adapting CRISPR Cas9 dropout screens to in vivo PDX models of acute leukemias
    Ludwig, R.
    Amend, D.
    Bahrami, E.
    Jeremias, I
    KLINISCHE PADIATRIE, 2022, 234 (03): : 183 - 183
  • [24] In Vivo Transcriptional Activation Using CRISPR/Cas9 in Drosophila
    Lin, Shuailiang
    Ewen-Campen, Ben
    Ni, Xiaochun
    Housden, Benjamin E.
    Perrimon, Norbert
    GENETICS, 2015, 201 (02) : 433 - +
  • [25] Unexpected mutations after CRISPR–Cas9 editing in vivo
    Kellie A Schaefer
    Wen-Hsuan Wu
    Diana F Colgan
    Stephen H Tsang
    Alexander G Bassuk
    Vinit B Mahajan
    Nature Methods, 2017, 14 : 547 - 548
  • [26] The CRISPR/CAS9 world
    Perini, Giovanni
    MOLECULAR CYTOGENETICS, 2017, 10
  • [27] What is CRISPR/Cas9?
    Redman, Melody
    King, Andrew
    Watson, Caroline
    King, David
    ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION, 2016, 101 (04): : 213 - 215
  • [28] CRISPR-Cas9 for Drug Discovery in Oncology
    Guichard, Sylvie M.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 50: PLATFORM TECHNOLOGIES IN DRUG DISCOVERY AND VALIDATION, 2017, 50 : 61 - 85
  • [29] CRISPR/CAS9 Technologies
    Williams, Bart O.
    Warman, Matthew L.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 (05) : 883 - 888
  • [30] Advances in CRISPR/Cas9
    Zhu, Youmin
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
12345